Laurence I. Wu
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Estrogen and related hormone effects, Synthesis and Reactions of Organic Compounds, Protein Kinase Regulation and GTPase Signaling, Computational Drug Discovery Methods
Most-Cited Works
- → Discovery and Preclinical Studies of (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an In Vivo Active Potent VEGFR-2 Inhibitor(2006)132 cited
- → Enantioselective total synthesis of miroestrol(1993)87 cited
- → New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 1. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Discovery and Variation of the 5-Keto Substituent(1998)53 cited
- → New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 3. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations at the 5 Position(1998)44 cited
- → New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 2. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations of the Dihydrobenzofuran Ring(1998)34 cited
- → Design, synthesis, and structure–activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors(2005)22 cited
- → Preference for photodissociation over internal [2 + 2]-cycloaddition during irradiation of an unsaturated α,β-enone(1994)12 cited